Login
$EVMN
$7.10 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Luis Peña Also a director
President & Chief Executive Officer and Director
63 Not stated $11,022,670
Luis C. Pena
President & CEO
Title from the Form 4 dated Sep 30, 2026
Not stated Not stated Not reported
Kyle Carver, M.B.A., C.P.A.
Chief Financial Officer
38 Since 2022
4 years
$4,404,643
Eugene A. Bauer, M.D. Also a director
Chief Medical Officer and Director
83 Not stated Not reported
Gregory S. Moss
Chief Business and Legal Officer, Corporate Secretary and Chief Compliance Officer
42 Since 2022
4 years
$4,600,966
Jeegar Patel
Chief Scientific Officer
48 Since 2022
4 years
Not reported
Janice Drew
Chief of Development Operations
63 Since 2020
6 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
6 of 8
stated in the proxy
Average tenure
4.8 years
from year joined
CEO also chairs the board
No
Benjamin F. McGraw, III
Director Age On board Independent Other public boards 2025 pay Source
Benjamin F. McGraw, III
77 2020
6 years
Independent Aerie Pharmaceuticals Not stated
Luis Peña
63 2020
6 years
Not independent None stated Paid as CEO
Eugene A. Bauer
83 2020
6 years
Not independent None stated Not stated
Rob Hopfner
53 2020
6 years
Independent None stated Not stated
Derek DiRocco
45 2024
2 years
Independent None stated Not stated
Felice Verduyn-van Weegen
39 2021
5 years
Independent None stated Not stated
David E. Cohen
61 2020
6 years
Independent None stated $484,577
Arthur Kirsch
74 2025
1 year
Independent Atea Pharmaceuticals, Inc. $451,244

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 21, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support